- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 13/615 - Adamantanes
Patent holdings for IPC class C07C 13/615
Total number of patents in this class: 45
10-year publication summary
1
|
6
|
1
|
0
|
1
|
4
|
0
|
1
|
5
|
3
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Idemitsu Kosan Co., Ltd. | 4220 |
5 |
The United States of America as represented by the Secretary of the Navy | 2750 |
3 |
Sumitomo Bakelite Co., Ltd. | 1499 |
3 |
Mitsubishi Gas Chemical Company, Inc. | 3465 |
2 |
Material Science Co., Ltd. | 39 |
2 |
Merck Patent GmbH | 5823 |
1 |
Canon Inc. | 39960 |
1 |
Intel Corporation | 47005 |
1 |
Semiconductor Energy Laboratory Co., Ltd. | 11416 |
1 |
AMOREPACIFIC Corporation | 2829 |
1 |
Amyris, Inc. | 372 |
1 |
Chase Pharmaceuticals Corporation | 28 |
1 |
China Petroleum & Chemical Corporation | 1908 |
1 |
Dexerials Corporation | 1967 |
1 |
Dr. Reddy's Laboratories Limited | 552 |
1 |
Justus-Liebig-Universitat Giessen | 100 |
1 |
JX Nippon Oil & Energy Corporation | 999 |
1 |
Kyoto University | 2800 |
1 |
Liaoning Lifeng Scientific & Technology Development Company Ltd. | 11 |
1 |
MERZ PHARMA GmbH & CO. KGaA | 613 |
1 |
Other owners | 15 |